The December 2025 quarter showcased the company's ability to drive topline growth whilst simultaneously exposing critical profitability challenges. Net sales reached ₹898.98 crores in Q3 FY26, marking a 28.31% year-on-year increase, though declining 2.18% sequentially from Q2 FY26's ₹919.03 crores. For the nine-month period ending December 2025, cumulative revenues stood at ₹2,618.04 crores, representing a 23.62% surge compared to the same period in the previous fiscal year.
However, the revenue growth story was overshadowed by a sharp contraction in profitability metrics. Net profit for Q3 FY26 declined to ₹29.50 crores from ₹46.69 crores in Q2 FY26, representing a 36.82% quarter-on-quarter fall. On a year-on-year basis, profit remained nearly flat at -0.20%, indicating the company is struggling to convert revenue growth into bottom-line expansion. The nine-month cumulative profit of ₹119.06 crores showed a modest 12.92% year-on-year growth, significantly lagging the revenue growth rate.
| Quarter | Net Sales (₹ Cr) | QoQ Growth | Net Profit (₹ Cr) | QoQ Growth | PAT Margin |
|---|---|---|---|---|---|
| Dec'25 | 898.98 | -2.18% | 29.50 | -36.82% | 3.28% |
| Sep'25 | 919.03 | +14.87% | 46.69 | +8.91% | 5.08% |
| Jun'25 | 800.03 | +7.26% | 42.87 | +58.19% | 5.36% |
| Mar'25 | 745.86 | +6.45% | 27.10 | -8.32% | 3.63% |
| Dec'24 | 700.65 | -7.68% | 29.56 | -35.39% | 4.22% |
| Sep'24 | 758.92 | +10.04% | 45.75 | +47.82% | 6.03% |
| Jun'24 | 689.67 | — | 30.95 | — | 4.49% |
Financial Performance: Margin Compression Amid Cost Pressures
The quarter's most concerning development was the severe compression in operating margins. Operating profit margin (excluding other income) contracted sharply to 7.57% in Q3 FY26 from 11.22% in Q2 FY26 and 8.96% in Q3 FY25. This 364-basis-point sequential decline signals deteriorating operational efficiency despite volume growth. The operating profit (PBDIT excluding other income) stood at ₹68.02 crores, down 33.99% quarter-on-quarter from ₹103.07 crores.
Employee costs rose to ₹84.54 crores in Q3 FY26, up 1.45% sequentially and 33.96% year-on-year, reflecting wage inflation and potentially increased headcount to support expanded operations. For the nine-month period, employee costs aggregated ₹245.76 crores, marking a 23.48% year-on-year increase that outpaced revenue growth in percentage terms.
The interest burden emerged as a critical drag on profitability. Interest expenses climbed to ₹36.95 crores in Q3 FY26, up marginally from ₹36.67 crores in Q2 FY26 but significantly higher than ₹24.61 crores in Q3 FY25—a 50.18% year-on-year surge. For the nine-month period, cumulative interest costs reached ₹105.33 crores, representing a 44.44% year-on-year increase. This escalating interest burden reflects the company's elevated debt levels and rising borrowing costs, with long-term debt standing at ₹1,038.19 crores as of March 2025, up from ₹680.48 crores in the previous year.
Depreciation expenses increased to ₹35.41 crores in Q3 FY26 from ₹34.47 crores in Q2 FY26, reflecting the company's ongoing capital expenditure programme. Fixed assets grew to ₹1,732.31 crores by March 2025 from ₹1,509.89 crores in March 2024, indicating substantial capacity expansion efforts. Profit before tax declined 45.86% quarter-on-quarter to ₹31.03 crores, whilst the tax rate dropped to an unusually low 4.93% in Q3 FY26 compared to 18.53% in Q2 FY26, providing some relief to the bottom line.
Critical Concern: Non-Operating Income Dependency
Other income surged to ₹35.37 crores in Q3 FY26, representing 113.99% of profit before tax—a worrying indicator of earnings quality. This suggests the company's core operations generated a profit before tax of just ₹-4.34 crores when excluding non-operating income, highlighting fundamental operational challenges. For the nine-month period, other income totalled ₹85.21 crores, accounting for 59.80% of cumulative PBT, significantly above healthy levels.
Balance Sheet Concerns: Rising Leverage and Working Capital Pressure
The company's balance sheet reveals mounting financial stress. Long-term debt surged 52.56% to ₹1,038.19 crores in FY25 from ₹680.48 crores in FY24, pushing the debt-to-equity ratio to concerning levels. With shareholder funds of ₹1,466.43 crores, the debt-equity ratio stood at approximately 0.71 times, though net debt to equity averaged 0.86 times over recent periods, indicating moderate but rising leverage.
The debt-to-EBITDA ratio averaged 3.53 times, suggesting the company would require over three and a half years of current EBITDA generation to repay its debt—a level that warrants caution. The interest coverage ratio, measured by EBIT to interest, averaged 5.08 times, which is adequate but declining. In Q3 FY26, operating profit to interest coverage dropped to just 1.84 times, the lowest in recent quarters, signalling deteriorating debt servicing capacity.
Working capital management showed mixed signals. Trade payables increased to ₹718.89 crores in FY25 from ₹688.08 crores in FY24, whilst current assets rose to ₹1,557.88 crores from ₹1,381.56 crores. Cash flow from operations remained healthy at ₹166 crores in FY25, though down from ₹245 crores in FY24. However, the company deployed ₹419 crores in investing activities during FY25, primarily for capacity expansion, necessitating ₹247 crores of financing inflows.
| Metric | Mar'25 | Mar'24 | Mar'23 | Change (YoY) |
|---|---|---|---|---|
| Shareholder Funds (₹ Cr) | 1,466.43 | 1,347.51 | 1,298.11 | +8.83% |
| Long-Term Debt (₹ Cr) | 1,038.19 | 680.48 | 546.58 | +52.56% |
| Fixed Assets (₹ Cr) | 1,732.31 | 1,509.89 | 1,373.66 | +14.73% |
| Cash & Equivalents (₹ Cr) | 18.00 | 24.00 | 32.00 | -25.00% |
Return Ratios: Quality Metrics Under Pressure
Return on equity (ROE) and return on capital employed (ROCE) metrics paint a concerning picture. Average ROE stood at 17.89% over the measurement period, which appears healthy on the surface. However, the latest ROE calculation shows a sharp decline to 9.49%, indicating deteriorating capital efficiency. This compression reflects the profit margin squeeze and rising capital base without commensurate earnings growth.
Average ROCE registered 16.19%, but the latest calculation reveals a dramatic fall to just 7.40%—less than half the historical average. This metric, which measures returns generated on total capital employed, suggests the company's recent capacity expansion investments are yet to generate adequate returns. The declining ROCE is particularly concerning given the substantial capital deployed, with fixed assets growing 14.73% year-on-year.
The company's sales to capital employed ratio averaged 1.24 times, indicating that for every rupee of capital employed, the company generates ₹1.24 of sales. Whilst this demonstrates reasonable asset turnover, the declining return ratios suggest pricing pressures or cost inflation are eroding profitability faster than volume growth can compensate.
Five-Year Growth Trajectory: Mixed Signals
Over the past five years, Cosmo First achieved sales growth of 9.49% annually, demonstrating steady topline expansion. However, EBIT growth contracted at -5.93% annually during the same period, highlighting the fundamental disconnect between revenue growth and operational profitability. This divergence underscores structural margin pressures that have persisted across business cycles.
Industry Context: Packaging Sector Dynamics
The flexible packaging industry in India has witnessed robust demand driven by the consumer goods sector, e-commerce growth, and increasing preference for convenient packaging solutions. BOPP films, Cosmo First's core product category, serve diverse applications including food packaging, labels, and industrial uses. The sector benefits from India's expanding middle class and rising consumption patterns.
However, the industry faces headwinds from volatile raw material costs, particularly polypropylene resin prices which are linked to crude oil fluctuations. Intense competition from domestic and international players has compressed pricing power, forcing manufacturers to compete on volume rather than value. Additionally, environmental regulations and sustainability concerns are pushing the industry towards recyclable and eco-friendly solutions, requiring fresh capital investments.
Cosmo First's capacity expansion strategy aligns with industry growth prospects, but the execution challenges are evident in deteriorating margins. The company's ability to pass on raw material cost increases to customers appears limited, suggesting weak bargaining power in its customer relationships. The elevated interest burden from debt-funded expansion further constrains profitability during this transitional phase.
Peer Comparison: Valuation Discount Reflects Concerns
| Company | P/E (TTM) | P/BV | ROE (%) | Debt/Equity | Div Yield (%) |
|---|---|---|---|---|---|
| Cosmo First | 13.11 | 1.24 | 17.89 | 0.86 | 0.55 |
| Polyplex Corpn | 36.16 | 0.66 | 8.30 | -0.03 | 0.77 |
| TCPL Packaging | 21.37 | 3.91 | 21.02 | 1.01 | 1.04 |
| XPRO India | 168.95 | 3.16 | 16.14 | 0.07 | 0.21 |
| Jindal Poly Film | NA (Loss Making) | 0.49 | 14.07 | -0.01 | 1.29 |
| Mold-Tek Pack. | 27.17 | 2.76 | 14.20 | 0.33 | 0.72 |
Cosmo First trades at a significant valuation discount to most packaging sector peers, with a P/E ratio of 13.11 times compared to the sector median of approximately 27 times (excluding outliers). The company's price-to-book ratio of 1.24 times is also below the peer average of approximately 2.2 times, suggesting the market is pricing in concerns about future profitability and return generation.
Notably, Cosmo First's historical average ROE of 17.89% ranks amongst the highest in the peer group, surpassing most competitors except TCPL Packaging (21.02%). However, this historical strength is undermined by the sharp recent deterioration to 9.49% in the latest calculation. The company's debt-to-equity ratio of 0.86 times is higher than several peers, reflecting its aggressive expansion strategy and contributing to the valuation discount.
The dividend yield of 0.55% is amongst the lowest in the peer group, with the company paying out just 7.87% of profits as dividends. This low payout ratio suggests management is retaining earnings for growth investments, though the declining returns on capital raise questions about capital allocation efficiency.
Valuation Analysis: Attractive Entry Point or Value Trap?
At the current price of ₹730.20, Cosmo First trades at 13.11 times trailing twelve-month earnings, representing a 23% discount to the industry P/E of 17 times. The price-to-book ratio of 1.24 times compares to a book value per share of ₹558.64, suggesting the stock trades at a modest 24% premium to book value—reasonable for a company with historical ROE above 17%.
The EV/EBITDA multiple of 9.73 times appears reasonable for a manufacturing business, though the elevated debt levels inflate the enterprise value. The EV/Sales ratio of 0.96 times indicates the market values the company at nearly its annual revenue, which is typical for capital-intensive manufacturing businesses with moderate margins.
The PEG ratio of 0.65 suggests the stock is undervalued relative to its growth prospects, as a PEG below 1.0 typically indicates attractive valuation. However, this metric must be viewed cautiously given the negative five-year EBIT growth of -5.93%, which raises questions about sustainable earnings growth.
The valuation grade has oscillated between "Attractive" and "Fair" multiple times during 2025, most recently settling on "Attractive" since mid-August 2025. This assessment reflects the low absolute valuation multiples, though investors must weigh this against deteriorating operational metrics and financial trend concerns.
Shareholding Pattern: Stable Promoter Base, Declining Institutional Interest
| Category | Dec'25 | Sep'25 | Jun'25 | Mar'25 | QoQ Change |
|---|---|---|---|---|---|
| Promoter | 40.86% | 40.86% | 40.98% | 40.98% | 0.00% |
| FII | 2.68% | 3.24% | 3.49% | 3.12% | -0.56% |
| Mutual Funds | 0.01% | 0.01% | 0.01% | 0.01% | 0.00% |
| Other DII | 0.83% | 0.46% | 0.67% | 0.09% | +0.37% |
| Non-Institutional | 55.62% | 55.42% | 54.85% | 55.80% | +0.20% |
Promoter holding has remained stable at 40.86% in the December 2025 quarter, unchanged from September 2025. The promoter group, led by Ashok Jaipuria with a 36.14% beneficial stake, demonstrates strong commitment with zero pledging of shares—a positive indicator of promoter confidence and financial stability.
However, foreign institutional investor (FII) holdings declined to 2.68% in Q3 FY26 from 3.24% in Q2 FY26, marking the third consecutive quarter of FII selling. Since March 2024, when FII holding stood at 3.99%, foreign investors have reduced their stake by 131 basis points, suggesting waning institutional confidence in the company's near-term prospects.
Mutual fund participation remains negligible at 0.01%, having collapsed from 0.51% in December 2024. This dramatic exit by domestic institutional investors is particularly concerning, as mutual funds typically conduct thorough fundamental analysis before exiting positions. The total institutional holding of just 3.52% (combining FIIs, mutual funds, and insurance) is amongst the lowest in the packaging sector, limiting liquidity and institutional support for the stock.
Non-institutional investors, comprising retail and high-net-worth individuals, hold 55.62% of the equity, reflecting the stock's small-cap nature and limited institutional coverage. The gradual increase in retail holdings suggests individual investors are accumulating shares at current depressed valuations, though this could also indicate weak hands in the shareholder base.
Stock Performance: Recent Recovery Masks Deeper Weakness
| Period | Stock Return | Sensex Return | Alpha |
|---|---|---|---|
| 1 Week | +18.32% | -1.14% | +19.46% |
| 1 Month | +13.91% | -1.20% | +15.11% |
| 3 Months | -9.28% | -2.19% | -7.09% |
| 6 Months | -31.15% | +2.59% | -33.74% |
| YTD | +6.29% | -3.04% | +9.33% |
| 1 Year | +11.87% | +8.52% | +3.35% |
| 3 Years | +1.28% | +36.73% | -35.45% |
| 5 Years | +119.87% | +60.30% | +59.57% |
The stock's recent performance presents a tale of two narratives. Over the past week, Cosmo First surged 18.32%, dramatically outperforming the Sensex which declined 1.14%, generating positive alpha of 19.46 percentage points. The one-month return of 13.91% similarly outpaced the benchmark, suggesting a technical bounce from oversold levels.
However, zooming out reveals significant underperformance. The six-month return of -31.15% contrasts sharply with the Sensex's +2.59% gain, resulting in negative alpha of -33.74 percentage points. The stock touched a 52-week low of ₹532.95 and currently trades 44.13% below its 52-week high of ₹1,306.85, indicating substantial value destruction over the medium term.
The three-year return of just 1.28% versus the Sensex's 36.73% gain highlights chronic underperformance, with negative alpha of -35.45 percentage points. This persistent lag reflects the market's recognition of deteriorating fundamentals and declining return ratios. Interestingly, the five-year return of 119.87% demonstrates the stock performed well in earlier years, suggesting recent operational challenges represent a departure from historical performance.
The stock's beta of 1.52 indicates high volatility, with price movements 52% more volatile than the broader market. The volatility of 53.32% classifies the stock in the "high risk, medium return" category, with a Sharpe ratio that suggests returns have not adequately compensated investors for the elevated risk undertaken.
Technical Analysis: Mildly Bearish Trend with Key Resistance Levels
From a technical perspective, Cosmo First's trend classification changed to "Mildly Bearish" on February 12, 2026, at ₹699.55, upgrading from the previous "Bearish" designation. The stock trades below all major moving averages—the 5-day MA at ₹656.09, 20-day MA at ₹619.24, 50-day MA at ₹661.65, 100-day MA at ₹749.97, and 200-day MA at ₹879.50—indicating persistent selling pressure across multiple timeframes.
The immediate support level sits at the 52-week low of ₹532.95, approximately 27% below current levels. Immediate resistance appears at the 20-day moving average of ₹619.24, which the stock recently reclaimed. Major resistance zones exist at ₹749.97 (100-day MA) and ₹879.50 (200-day MA), representing 2.7% and 20.4% upside respectively from current levels.
Technical indicators present mixed signals. The MACD shows "Mildly Bullish" on the weekly timeframe but "Mildly Bearish" monthly, suggesting short-term momentum improvement within a broader downtrend. The RSI indicates no clear signal weekly but remains "Bearish" monthly, confirming the stock hasn't escaped oversold territory definitively. On-Balance Volume (OBV) registers "Bullish" on both weekly and monthly timeframes, suggesting accumulation despite price weakness—a potentially positive divergence.
Delivery volumes increased 105.57% over the trailing one-month period compared to the previous month, with recent delivery percentage at 29.51% of total volume. This uptick in delivery-based buying suggests genuine investor interest rather than speculative trading, though the five-day average delivery percentage of 54.71% indicates recent sessions saw more speculative activity.
Investment Thesis: Attractive Valuation Offset by Operational Headwinds
The investment case for Cosmo First presents a complex risk-reward equation. On the positive side, the stock trades at attractive valuation multiples with a P/E of 13.11 times—a 23% discount to industry peers—and a reasonable price-to-book of 1.24 times. The company has demonstrated ability to grow revenues at healthy rates, with 28.31% year-on-year growth in Q3 FY26 and 23.62% for the nine-month period.
The quality grade of "Average" reflects mixed fundamentals. Historical average ROE of 17.89% and ROCE of 16.19% demonstrate past capital efficiency, whilst zero promoter pledging and stable promoter holding of 40.86% indicate committed management. The company operates in a structurally growing packaging sector with long-term tailwinds from consumption growth and e-commerce expansion.
However, significant concerns temper the investment thesis. The financial trend classification of "Negative" reflects deteriorating operational metrics, including the sharp quarterly profit decline of 36.82%, margin compression from 11.22% to 7.57%, and concerning dependence on other income which constituted 113.99% of PBT in Q3 FY26. The latest ROE of just 9.49% and ROCE of 7.40% represent dramatic declines from historical averages, questioning whether past performance can be sustained.
Rising leverage poses another risk, with long-term debt surging 52.56% year-on-year and interest costs climbing 50.18% in Q3 FY26 versus the prior year. The debt-to-EBITDA ratio of 3.53 times and declining interest coverage (operating profit to interest of just 1.84 times in Q3) constrain financial flexibility. The "Mildly Bearish" technical trend and position below all moving averages suggest the market remains sceptical about near-term recovery prospects.
Key Strengths & Risk Factors
KEY STRENGTHS ✅
- Attractive Valuation: P/E of 13.11x represents 23% discount to industry average of 17x, with PEG ratio of 0.65 suggesting undervaluation relative to growth.
- Strong Revenue Growth: 28.31% YoY sales growth in Q3 FY26 and 23.62% for nine-month period demonstrates robust demand for products.
- Stable Promoter Base: 40.86% promoter holding with zero pledging indicates strong management commitment and financial stability.
- Historical Capital Efficiency: Average ROE of 17.89% and ROCE of 16.19% rank amongst the best in the packaging sector peer group.
- Structural Industry Growth: Operates in expanding flexible packaging market driven by consumption growth, e-commerce, and organised retail penetration.
- Capacity Expansion: Fixed assets grew 14.73% to ₹1,732.31 crores, positioning company for future volume growth once utilisation improves.
- Long-term Track Record: Five-year return of 119.87% versus Sensex's 60.30% demonstrates historical wealth creation capability.
KEY CONCERNS ⚠️
- Severe Margin Compression: Operating margin (excl OI) contracted to 7.57% from 11.22% QoQ—a 364-basis-point decline signalling operational stress.
- Rising Interest Burden: Interest costs surged 50.18% YoY to ₹36.95 crores in Q3, with nine-month interest up 44.44%, severely impacting profitability.
- Deteriorating Return Ratios: Latest ROE of 9.49% and ROCE of 7.40% represent sharp declines from averages of 17.89% and 16.19% respectively.
- Other Income Dependency: Other income constituted 113.99% of PBT in Q3, indicating core operations generated negative profit before tax of ₹-4.34 crores.
- Elevated Leverage: Long-term debt jumped 52.56% YoY to ₹1,038.19 crores, with debt-to-EBITDA at 3.53x and declining interest coverage.
- Institutional Exodus: FII holdings declined from 3.99% to 2.68% over four quarters; mutual fund stake collapsed from 0.51% to 0.01%.
- Negative Five-Year EBIT Growth: EBIT contracted at -5.93% annually over five years despite 9.49% sales CAGR, highlighting persistent margin pressures.
- High Volatility: Beta of 1.52 and volatility of 53.32% classify stock as high risk with inadequate risk-adjusted returns.
Outlook: What to Watch in Coming Quarters
POSITIVE CATALYSTS 📈
- ✓ Margin Recovery: Operating margin improvement back towards 10-11% levels would signal successful cost management and pricing power restoration.
- ✓ Capacity Utilisation Gains: Improved utilisation of expanded capacity could drive operating leverage and ROCE improvement.
- ✓ Debt Reduction: Cash flow generation directed towards debt repayment would ease interest burden and improve financial flexibility.
- ✓ Institutional Re-entry: Fresh buying by FIIs or mutual funds would validate improving fundamentals and provide stock support.
- ✓ Stable Raw Material Costs: Benign polypropylene resin prices would support margin expansion and earnings visibility.
RED FLAGS 🚨
- ✗ Further Margin Erosion: Operating margins falling below 7% would indicate deeper structural issues requiring management intervention.
- ✗ Interest Coverage Below 1.5x: Operating profit to interest ratio declining further would raise debt servicing concerns.
- ✗ Continued FII Selling: Further reduction in already-low institutional holdings would limit liquidity and valuation support.
- ✗ Working Capital Deterioration: Rising debtor days or inventory levels would indicate demand weakness or collection challenges.
- ✗ Promoter Stake Reduction: Any decline in promoter holding from current 40.86% would signal waning confidence.
Investors should closely monitor quarterly margin trends, interest coverage ratios, and debt reduction progress. The Q4 FY26 results will be critical in determining whether Q3's margin compression was a temporary aberration or the beginning of a sustained downtrend. Management commentary on capacity utilisation, order book visibility, and pricing environment will provide insights into near-term earnings trajectory.
The stock's technical setup suggests it needs to convincingly reclaim the 100-day moving average at ₹749.97 to signal a trend reversal. Until then, the path of least resistance remains sideways to lower, with support at ₹532.95 representing a critical level. Any break below this 52-week low would likely trigger fresh selling pressure and test investor conviction.
The Verdict: Cautious Approach Warranted Despite Valuation Appeal
Score: 34/100
For Fresh Investors: Avoid initiating positions at current levels. Whilst valuation multiples appear attractive, deteriorating operational metrics, margin compression, and rising leverage pose significant near-term risks. The negative financial trend, declining return ratios, and institutional exodus suggest fundamental challenges that require resolution before committing capital. Wait for tangible evidence of margin stabilisation and debt reduction before considering entry.
For Existing Holders: Consider reducing exposure on any technical bounce towards ₹750-800 levels. The sharp profit decline, unsustainable dependence on other income, and weakening interest coverage warrant a cautious stance. Long-term holders with high conviction may maintain core positions but should closely monitor quarterly results for signs of operational turnaround. Set mental stop-loss at ₹530 (52-week low) to limit downside risk.
Fair Value Estimate: ₹650-700 (11-4% downside from current levels) based on sustainable earnings normalisation at lower margin profile and elevated debt burden. Upside potential exists if management successfully executes margin recovery and deleveraging strategy, but risks currently outweigh rewards.
Rationale: The SELL rating reflects the confluence of negative financial trends, deteriorating quality metrics, and bearish technical setup despite attractive valuation. Whilst the P/E discount to peers appears compelling, it reflects genuine operational concerns rather than market inefficiency. The dramatic decline in ROE from 17.89% to 9.49% and ROCE from 16.19% to 7.40%, combined with 113.99% other income dependency and 50.18% YoY interest cost surge, indicate fundamental challenges requiring time to resolve. Institutional selling, negative alpha over medium-term periods, and position below all moving averages reinforce caution. Investors should prioritise capital preservation and await clearer signs of operational inflection before deploying fresh capital.
Note— ROCE = (EBIT - Other income)/(Capital Employed - Cash - Current Investments)
⚠️ Investment Disclaimer
This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results. The views expressed are based on data available as of February 16, 2026, and are subject to change based on market conditions and company developments.
